Tumor-liver interface in MRI of liver metastasis enables prediction of EGFR mutation in patients with lung cancer: A proof-of-concept study.

导出 LinkOut

翻译打印收藏纠错

作者： Shaoping,Hou ^[1] ; Hongbo,Wang ^[2] ; Xiaoyu,Wang ^[3] ; Huanhuan,Chen ^[4] ; Boyu,Zhou ^[1] ; Ruiqing,Meng ^[1] ; Xianzheng,Sha ^[1] ; Shijie,Chang ^[1] ; Huan,Wang ^[5] ; Wenyan,Jiang ^[6]

作者单位： School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, P.R. China. ^[1] Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China. ^[2] Department of Radiology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, P.R. China. ^[3] Department of Oncology, Shengjing Hospital, Shenyang, Liaoning, P.R. China. ^[4] Radiation Oncology Department of Thoracic Cancer, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, P.R. China. ^[5] Department of Scientific Research and Academic, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, P.R. China. ^[6]

关键词 EGFR NSCLC liver metastasis radiomics tumor-liver interface

主题词人类(Humans);肺肿瘤(Lung Neoplasms);回顾性研究(Retrospective Studies);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);磁共振成像(Magnetic Resonance Imaging);肝肿瘤(Liver Neoplasms);突变(Mutation)

DOI 10.1002/mp.16581

PMID 37408393

发布时间 2024-02-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交